These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7165299)

  • 1. A simple purification method for enterotoxin F produced by Staphylococcus aureus and some properties of the toxin.
    Notermans S; Dufrenne JB
    Antonie Van Leeuwenhoek; 1982 Dec; 48(5):447-55. PubMed ID: 7165299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing.
    Blomster-Hautamaa DA; Kreiswirth BN; Novick RP; Schlievert PM
    Biochemistry; 1986 Jan; 25(1):54-9. PubMed ID: 3954993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.
    Bergdoll MS; Crass BA; Reiser RF; Robbins RN; Davis JP
    Lancet; 1981 May; 1(8228):1017-21. PubMed ID: 6112412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some physicochemical properties of toxic-shock toxin.
    Reiser RF; Robbins RN; Khoe GP; Bergdoll MS
    Biochemistry; 1983 Aug; 22(16):3907-12. PubMed ID: 6615808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. I. Purification of enterotoxin C2.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):148-58. PubMed ID: 237564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, purification, and some physicochemical properties of staphylococcal enterotoxin C3.
    Reiser RF; Robbins RN; Noleto AL; Khoe GP; Bergdoll MS
    Infect Immun; 1984 Sep; 45(3):625-30. PubMed ID: 6469349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
    Reeves MW; Arko RJ; Chandler FW; Bridges NB
    Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.
    Reeves MW; Pine L; Feeley JC; Wells DE
    Infect Immun; 1984 Nov; 46(2):590-7. PubMed ID: 6500702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
    Bonventre PF; Weckbach L; Staneck J; Schlievert PM; Thompson M
    Infect Immun; 1983 Jun; 40(3):1023-9. PubMed ID: 6189784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of staphylococcal enterotoxin type B and a study of its physicochemical, biological and immunological properties].
    Fluer FS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):36-41. PubMed ID: 6362299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome.
    Vergeront JM; Evenson ML; Crass BA; Davis JP; Bergdoll MS; Wand PJ; Noble JH; Petersen GK
    J Infect Dis; 1982 Oct; 146(4):456-9. PubMed ID: 7119476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1975 Sep; 42(3):91-8. PubMed ID: 172828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome.
    Bergdoll MS; Crass BA; Reiser RF; Robbins RN; Lee AC; Chesney PJ; Davis JP; Vergeront JM; Wand PJ
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):969-71. PubMed ID: 7091977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
    Parsonnet J; Hickman RK; Eardley DD; Pier GB
    J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis.
    Nissen D; Pedersen LJ; Skov PS; Vejlsgaard GL; Poulsen LK; Jarløv JO; Karlsmark T; Nolte H
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):403-8. PubMed ID: 9396971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and purity assessment of toxic shock syndrome toxin 1.
    Rosten PM; Bartlett KH; Chow AW
    Rev Infect Dis; 1989; 11 Suppl 1():S110-5; discussion S115-6. PubMed ID: 2494689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1.
    Ho G; Campbell WH; Carlson E
    J Clin Microbiol; 1989 Jan; 27(1):210-2. PubMed ID: 2492300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and some physicochemical properties of staphylococcal enterotoxin D.
    Chang HC; Bergdoll MS
    Biochemistry; 1979 May; 18(10):1937-42. PubMed ID: 107962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. II. Purification of enterotoxin A.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):159-64. PubMed ID: 806302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.